학술논문
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Document Type
Article
Author
Costa Clemens, S.A.; Aley, P.; Bibi, S.; Cantrell, L.; Liu, X.; Lambe, T.; Voysey, M.; Weckx, L.; Clemens, R.; Almeida Mendes, A.V.; da Guarda, S.N.F.; Franco, M.M.; de Avila Mendonça, R.N.; Queiroz Oliveira, I.S.; Salvador, N.; de Freitas Souza, B.S.; Fraga, M.; Ramos Souza, A.; Silveira, M.B.V.; de Nobrega, M.M.; de Moraes Pinto, M.I.; Gonzalez, I.G.S.; Dejnirattisai, W.; Mongkolsapaya, J.; Supasa, P.; Screaton, G.R.; Pollard, A.J.; Bittaye, M.; Woods, D.; Davies, S.; Smith, H.; Ulaszewska, M.; Sanders, H.; Mabette, R.; Vernon, S.; Valliji, Z.; Mead, G.; Tejpal, C.; Park, J.; Beveridge, A.; Eldawi, A.; Felle, S.; Muniz Martins, T.; Martins Medrado, C.L.; de Arruda Cordeiro Matos, L.J.
Source
In: The Lancet . (The Lancet, 5 February 2022, 399(10324):521-529)
Subject
Language
English
ISSN
1474547X
01406736
01406736